Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
Schmidt D, Kollan C, Bartmeyer B, Bremer V, Schikowski T, Friebe M, Schellberg S, Scholten S, Bickel M, Hanhoff N, Rüsenberg R, Schewe K; NEPOS study group. Schmidt D, et al. Among authors: scholten s. Infection. 2023 Jun;51(3):665-678. doi: 10.1007/s15010-022-01919-3. Epub 2022 Sep 27. Infection. 2023. PMID: 36168098 Free PMC article.
Telaprevir-containing triple therapy in acute HCV coinfection: The CHAT Study.
Boesecke C, Singh GKJ, Scholten SH, Lutz T, Baumgarten A, Schneeweiss SM, Trein A, Rausch M, Ingiliz P, Rockstroh JK, Nelson M; CHAT study group. Boesecke C, et al. Antivir Ther. 2017;22(7):619-623. doi: 10.3851/IMP3143. Epub 2017 Feb 27. Antivir Ther. 2017. PMID: 28240597 Clinical Trial.
Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
Bischoff J, Mauss S, Cordes C, Lutz T, Scholten S, Moll A, Jäger H, Cornberg M, Manns MP, Baumgarten A, Rockstroh JK. Bischoff J, et al. Among authors: scholten s. HIV Med. 2018 Apr;19(4):299-307. doi: 10.1111/hiv.12579. Epub 2018 Jan 25. HIV Med. 2018. PMID: 29368456 Free article.
Summary of German-Austrian HIV PrEP guideline.
Spinner CD, Lang GF, Boesecke C, Jessen H, Schewe K; German-Austrian PrEP consensus conference meeting 2018. Spinner CD, et al. HIV Med. 2019 Jul;20(6):368-376. doi: 10.1111/hiv.12724. Epub 2019 May 29. HIV Med. 2019. PMID: 31140708 Free article.
Tecovirimat for the treatment of severe Mpox in Germany.
Hermanussen L, Brehm TT, Wolf T, Boesecke C, Schlabe S, Borgans F, Monin MB, Jensen BO, Windhaber S, Scholten S, Jordan S, Lütgehetmann M, Wiesch JSZ, Addo MM, Mikolajewska A, Niebank M, Schmiedel S. Hermanussen L, et al. Among authors: scholten s. Infection. 2023 Oct;51(5):1563-1568. doi: 10.1007/s15010-023-02049-0. Epub 2023 Jun 5. Infection. 2023. PMID: 37273167 Free PMC article.
AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999-2018.
Pantke A, Kollan C, Gunsenheimer-Bartmeyer B, Jensen BO, Stephan C, Degen O, Schürmann D, Kurth T, Bremer V, Koppe U; HIV-1 Seroconverter Cohort and the ClinSurv HIV Cohort. Pantke A, et al. Infection. 2024 Apr;52(2):637-648. doi: 10.1007/s15010-024-02188-y. Epub 2024 Feb 21. Infection. 2024. PMID: 38381307 Free PMC article.
128 results